170601 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring one-carbon groups (2.1) Methyltransferases (general) (2.1.1.)
Sub-classes:Methods and kits for targeted cleavage and enrichment of Nucleic Acids for high-throughput analyses of user-defined genomic regions
#2ENZYME DIRECTED BIOMOLECULE LABELING
#3METHODS AND COMPOSITIONS FOR INHIBITING VIRAL METHYLTRANSFERASES
#4REPROGRAMMING OF SOMATIC CELLS
#5ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#6METHOD FOR QUANTITATIVE MONITORING MRNA CAPPING EFFICIENCY
#7SETDB1-MICROTUBULE INTERACTION AND USE THEREOF
#8COMPOSITION FOR PREVENTING OR TREATING NEUROMUSCULAR DISEASE, COMPRISING PRMT1 PROTEIN OR GENE ENCODING SAME
#9PHARMACEUTICAL COMPOSITION FOR THE CHEMICAL INHIBITION OF TGS1 IN THE THERAPEUTIC TREATMENT OF TELOMEROPATHIES
#10METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#11INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#12Methods and kits for quantifying adenosine-containing molecules
#13Biomarker of aging
#14STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES
#15INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#16METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#17INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#18FLUORESCENT BIOSENSOR FOR METHYLTRANSFERASE ASSAY
#19INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF
#20Reprogramming of somatic cells
#21STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#22CONVERSION OF ALPHA-HYDROXYALKYLATED RESIDUES IN BIOMOLECULES USING METHYLTRANSFERASES
#23Inhibitors of human EZH2, and methods of use thereof
#24COMPOSITIONS FOR TARGETED DNA METHYLATION AND THEIR USE
#25CHARACTERIZATION OF PRE-CANCER BIOMARKER FOR PROGNOSTIC SCREEN
#26Compositions and methods for treating cancer
#27METHODS OF INHIBITING PRMT5
#28FLUORESCENT MOLECULAR PROBES FOR USE IN ASSAYS THAT MEASURE TEST COMPOUND COMPETITIVE BINDING WITH SAM-UTILIZING PROTEINS
#29FLUORESCENT MOLECULAR PROBES FOR USE IN ASSAYS THAT MEASURE TEST COMPOUND COMPETITIVE BINDING WITH SAM-UTILIZING PROTEINS
#30DNA 5-methyl cytosine demethylation activity of vertebrate DNA methyltransferases
#31Method of treatment of SETDB1 expressing cancer
#32Method of selecting individualized brain cancer therapy
#33Inhibitors of human EZH2, and methods of use thereof
#34Reprogramming of somatic cells
#35Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases
#36METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#37Monoclonal antibody for the detection of SNAP/CLIP tag
#38Inhibitors of human EZH2, and methods of use thereof
#39Androgen receptor-dependent gene expression control
#40Inhibitors of human EZH2, and methods of use thereof
#41LUCIFERASE-LINKED ANALYSIS OF DNA-METHYLTRANSFERASE, PROTEIN METHYLTRANSFERASE AND S-ADENOSYLHOMOCYSTEINE AND USES THEREOF
#42Fluorescent molecular probes for use in assays that measure test compound competitive binding with SAM-utilizing proteins
#43USE OF PROTEIN ARGININE METHYLTRANSFERASES IN REGULATING HEMATOPOIETIC DIFFERENTIATION
#44PCNA METHYLTRANSFERASE
#45Detection Method for Methyltransferase Enzymatic Activity
#46Compositions for Inhibiting Growth of Cancer Stem Cells
#47Methods and kits for quantitative methyltransferase and demethylase measurements
#48Derivatization of biomolecules by covalent coupling of non-cofactor compounds using methyltransferases
#49Conversion of alpha-hydroxyalkylated residues in biomolecules using methyltransferases
#50Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer
#51Inhibitors of human EZH2 and methods of use thereof
#52JARID1B FOR TARGET GENE OF CANCER THERAPY AND DIAGNOSIS
#53Diagnosis and treatment of cancer
#54METHOD AND COMPOSITIONS FOR DETERMINING ENZYMATIC ACTIVITY AND SPECIFICITY OF METHYLTRANSFERASES
#55STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#56Methods for making cancer prognoses based on subcellular localization of biomarkers
#57Reprogramming of somatic cells
#58ASSAYS FOR S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASES
#59Methods of identifying agents that modulate methylation of VEGFR1 by SMYD3
#60RECONSTITUTED HISTONE METHYLTRANSFERASE COMPLEX AND METHODS OF IDENTIFYI NG MODULATORS THEREOF
#61Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancer
#62Method of identifying a potential substrates of an O-methyltransferase
#63Methods of modulating SMYD3 for treatment of cancer
#64Methylation detection
#65Inhibition of GASC1
#66Breast cancer related gene ZNFN3A1
#67Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators
#68Methods and compositions for assaying homocysteine
#69Androgen receptor-dependent gene expression control
#70High throughput screening assay for histone modifying enzyme modulators
#71Methods for making cancer prognoses based on subcellular localization of biomarkers
#72DEVELOPMENT OF A NOVEL ASSAY FOR MGMT (METHYL GUANINE METHYL TRANSFERASE)
#73Assays for S-adenosylmethionine (AdoMet)-dependent methyltransferase activity
#742-Methyl-6-solanylbenzoquinone methyltransferase as target for herbicides
#75Protein Arginine N-Methyltransferase 2 (PRMT-2)
#76Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
#77Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
#78Glycine N-methyltransferase monoclonal antibodies and methods of use therefor
#79Methods and compositions for overcoming resistance to biologic and chemotherapy
#80Histone h3methyltransferase polypeptide